Abstract
(BMJ. 2017;358:j3668) Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), are prescribed during pregnancy and are considered safe. Recent studies have raised concerns regarding the long-term neurodevelopmental effects, such as autism and attention-deficit/hyperactivity disorder, of these medications on the offspring. However, gaps exist in the knowledge of antidepressant use during pregnancy and risk of psychiatric disorders in the offspring. This population-based cohort study was performed to investigate the association between in utero antidepressant exposure and overall risk of psychiatric disorders in children.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
